AWP Litigation Takes New Twist As Abbott Seeks Sanctions Against DoJ
Executive Summary
Abbott is pursuing a new tactic in litigation over its average wholesale drug pricing. It is accusing the Department of Justice of failing to preserve evidence critical to its defense
You may also be interested in...
AWP Litigation: Three More Companies Ink Deals With DoJ; Roxane Sets A Record
The heavy docket of average wholesale price cases got a bit lighter as three pharma companies agreed to pay $421 million to settle claims they inflated the AWP of numerous drugs, thus increasing reimbursement levels.
AWP Litigation: Three More Companies Ink Deals With DoJ; Roxane Sets A Record
The heavy docket of average wholesale price cases got a bit lighter as three pharma companies agreed to pay $421 million to settle claims they inflated the AWP of numerous drugs, thus increasing reimbursement levels.
Sanofi Is Fifth Company To Sign AWP Settlement With DoJ, Pays $190 Mil.
While dozens of pharmaceutical companies are entangled in fraudulent pricing lawsuits, only five have inked a deal with the Department of Justice